Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00775346 · ClinicalTrials.gov registry record
A Multi-Center Study to Assess the Performance of Saturation Patterns.
A clinical trial of Obstructive Sleep Apnea and Sleep Apnea, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 92
- Enrollment target
- 3
- Study locations
NCT00775346: Completed study of Obstructive Sleep Apnea and Sleep Apnea, sponsored by Medtronic - MITG.
NCT00775346 is a study of Obstructive Sleep Apnea and Sleep Apnea that has completed, run by Medtronic - MITG. The registered enrollment target is 92 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (58% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00775346, a study of Obstructive Sleep Apnea and Sleep Apnea, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
- 3
- Study locations
Study Summary
A multi-center, prospective, single-visit study designed to acquire physiologic pulse oximeter waveform data during standard polysomnography (PSG) studies performed at multiple different Sleep Lab Centers.
Primary Outcome
Sensitivity and specificity were computed from the count of instances in which the Saturation Pattern Detection (SPD) index value (vs. Polysomnography) within a discrete ten minute interval correctly identified a Repetitive Reduction in Airflow (RRiA) as being present within that interval (True Positive), absent (True Negative), or incorrectly identified presence or absence (False Positive and False Negative, respectively). Sensitivity is True Positive divided by True Positive plus False Negativ
Conditions Studied
Study Locations (3)
Colorado
- SleepFit - Broomfield
Missouri
- Clayton Sleep Institute - Maplewood
New York
- Sleep Medicine Centers - West Seneca
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2008-08 |
| Est. Completion | 2008-10 |
What the finished NCT00775346 record still lists
NCT00775346 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (58% lower).
The record links to 4 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 0 interventions.
NCT00775346 reports a single indexed study location in Colorado, Missouri, New York.
Frequently Asked Questions
What is clinical trial NCT00775346 about?
NCT00775346 is a clinical study titled "A Multi-Center Study to Assess the Performance of Saturation Patterns.". A multi-center, prospective, single-visit study designed to acquire physiologic pulse oximeter waveform data during standard polysomnography (PSG) studies performed at multiple different Sleep Lab Centers.
What is the current status of trial NCT00775346?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2008-08. Estimated completion is 2008-10.
What conditions does trial NCT00775346 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Sleep Apnea, Sleep Disordered Breathing, Central Sleep Apnea.
Who is sponsoring clinical trial NCT00775346?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00775346 being conducted?
This trial has 3 study locations across Colorado, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00775346's enrollment target sits among peer trials
92 72nd of 155 higher than 84 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
RECRUITING · Phase 1
-
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
RECRUITING
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia